Lilly plans to build a new $3 billion facility to boost oral medicine manufacturing capacity in Europe for patients worldwide
Lilly reports third-quarter 2025 financial results, highlights R&D pipeline momentum and raises 2025 guidance
Lilly announces more than $1.2 billion investment in Puerto Rico facility to boost oral medicine manufacturing capacity in the United States
LillyDirect and Walmart Pharmacy launch first retail pick-up option with direct-to-consumer pricing for Zepbound
Lilly partners with NVIDIA to build the industry's most powerful AI supercomputer, supercharging medicine discovery and delivery for patients
Lilly announces roster of Team USA athletes for the Olympic and Paralympic Games Milano Cortina 2026, pledges to translate U.S. Olympic and Paralympic milestones into meaningful community impact
Lilly's Omvoh approved by U.S. FDA as a single-injection maintenance regimen in adults with ulcerative colitis
Lilly's Omvoh demonstrated early and sustained improvement in bowel urgency outcomes for patients with ulcerative colitis
Lilly's Verzenio® prolonged survival in HR+, HER2-, high-risk early breast cancer with two years of treatment
Lilly's oral GLP-1, orforglipron, demonstrated superior glycemic control in two successful Phase 3 trials, reconfirming its potential as a foundational treatment in type 2 diabetes
Lilly to present new clinical data for Verzenio and multiple novel pipeline programs at the 2025 European Society for Medical Oncology Annual Meeting
LaFleur Minerals Announces Brokered Private Placement of Gold-Linked Convertible Notes to Finance Restart of Gold Production at Beacon Gold Mill
